Making U.S. biotech more competitive with China's could help rare disease patients, experts say

Making U.S. biotech more competitive with China's could help rare disease patients, experts say

China is becoming a leader in biotech innovation. That offers hope to rare disease patients and presents a problem to American companies trying to save them.

Making U.S. biotech more competitive with China's could help rare disease patients, experts say – RamaOnHealthcare

Key Points- China is pumping money into its biotech industry, helping launch a new wave of labs and incubators in the country.- Experts say this could slow down American innovation in the biotech space.- China's growth presents a conundrum for rare disease patients.The growth of China's biotechnology sector has been staggering. Beijing is pumping money [...]

Makary cites higher FDA user fees as one key to counter China biotech

As China sees increased biotech investments, licensing deals and faster early-phase clinical trial starts, FDA Commissioner Marty Makary said his agency is reworking Phase 1 trial regulations to speed that entry process and tweaking user ...